Evidence map›Paper›PMID 35965283›Full record

Trial reportPediatrics2022

Text Message Reminders for the Second Dose of Influenza Vaccine for Children: An RCT.

Melissa S Stockwell, Laura P Shone, Ekaterina Nekrasova, Chelsea Wynn, Alessandra Torres, Miranda Griffith, Justine Shults, Rebecca Unger, Leigh Ann Ware, Chelsea Kolff and 5 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06657573 (AI-enabled Vaccine Chatbot for Improving Influenza Vaccination Uptake in Children), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06657573 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

AI-enabled Vaccine Chatbot for Improving Influenza Vaccination Uptake in Children: a Cluster Randomized Trial

TypeinterventionalSponsorFudan UniversityRan2024 to 2025Enrolled1,200ConditionsInfluenza VaccinesArmsAn AI-enabled chatbot tailored for influenza vaccine consultation
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Melissa S StockwellDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University, New York, New York.
Laura P ShonePrimary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Ekaterina NekrasovaDepartment of Pediatrics, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Chelsea WynnDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University, New York, New York.
Alessandra TorresPrimary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Miranda GriffithPrimary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Justine ShultsDepartment of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Rebecca UngerNorthwestern Children's Practice, Chicago, Illinois.
Leigh Ann WareBuilding Blocks Pediatrics, Pleasanton, Texas.
Chelsea KolffDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University, New York, New York.
Donna HarrisPrimary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Lindsay BerriganDepartment of Pediatrics, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Heather MontaguePrimary Care Research, American Academy of Pediatrics, Itasca, Illinois.
A Russell LocalioDepartment of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Alexander G FiksDepartment of Pediatrics, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Funding

Flu2Text: A Multi-Site Study assessing an Intervention for 2nd Dose of Influenza VaccineR01HD086045 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FIKS, ALEXANDER GABRIEL, STOCKWELL, MELISSA S · 2016 to 2019
$2.4M
NICHD NIH HHS R01 HD086045
6 · The paper itself

Abstract

BACKGROUND AND

objectivesAmong children requiring 2 influenza doses in a given season, second dose receipt nearly halves the odds of influenza. Nationally, many children do not receive both needed doses. This study sought to compare the effectiveness of text message reminders with embedded interactive educational information versus usual care on receipt and timeliness of the second dose of influenza vaccine.

methodsThis trial took place over the 2017 to 2018 and 2018 to 2019 influenza seasons among 50 pediatric primary care offices across 24 states primarily from the American Academy of Pediatrics' Pediatric Research in Office Settings practice-based research network. Caregiver-child dyads of children 6 months to 8 years in need of a second influenza vaccination that season were individually randomized 1:1 into intervention versus usual care, stratified by age and language within each practice. Intervention caregivers received automated, personalized text messages, including educational information. Second dose receipt by April 30 (season end) and by day 42 (2 weeks after second dose due date) were assessed using Mantel Haenszel methods by practice and language. Analyses were intention to treat.

resultsAmong 2086 dyads enrolled, most children were 6 to 23 months and half publicly insured. Intervention children were more likely to receive a second dose by season end (83.8% versus 80.9%; adjusted risk difference (ARD) 3.8%; 95% confidence interval [0.1 to 7.5]) and day 42 (62.4% versus 55.7%; ARD 8.3% [3.6 to 13.0]).

conclusionsIn this large-scale trial of primary care pediatric practices across the United States, text message reminders were effective in promoting increased and timelier second dose influenza vaccine receipt.

Indexed as

Influenza, HumanInfluenza VaccinesText MessagingChildHumansInfantReminder SystemsVaccinationInfluenza Vaccines

Identifiers

PMID35965283
PMCPMC9592065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.